0QF:FRA
Moderna Inc
€40,54
arrow_downward
-2,15%(-0,89) 1D
21 ພ.ພ., 17 ໂມງ 15 ນາທີ 42 ວິນາທີ GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
€41,08
High
€41,08
Low
€40,26
Mkt. cap
໑໘,໖໕ ຕື້
Avg. vol.
໑,໓໐ ພັນ
Volume
໓໘໐,໐໐
52-wk high
€50,70
52-wk low
€19,26
No. of employees
໕ ພັນ
News stories
From sources across the web
Reuters
·
33 ນາທີກ່ອນ
US FDA to hold expert committee meeting to review Moderna's flu vaccine
Seeking Alpha
·
1 ຊົ່ວໂມງກ່ອນ
Moderna to face FDA AdCom review for flu shot (MRNA:NASDAQ)
Yahoo Finance
·
2 ຊົ່ວໂມງກ່ອນ
Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. Wikipedia
About Moderna Inc
CEOStéphane Bancel
Employees4,7 ພັນ
Foundedກ.ຍ. 2010
Headquarters-
SectorBiotechnology
Websitemodernatx.com
AI content may include mistakes. Learn more